SEARCH

SEARCH BY CITATION

References

  • 1
    Brochu-Gaudreau K, Rehfeldt C, Blouin R et al. Adiponectin action from head to toe. Endocrine 2010;37:1132.
  • 2
    Magge SN, Stettler N, Koren D et al. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. J Clin Endocrinol Metab 2011;96:15491554.
  • 3
    Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266281.
  • 4
    Anderson JL, May HT, Horne BD et al.; Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106:963968.
  • 5
    Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des 2010;16:18961901.
  • 6
    Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions. Hypertension 2010;56:774779.
  • 7
    Young KA, Engelman CD, Langefeld CD et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009;94:33063313.
  • 8
    Gannagé-Yared MH, Chedid R, Khalife S et al. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009;160:965971.
  • 9
    Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphadhanakul B. The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine 2009;36:205210.
  • 10
    Vaidya A, Forman JP, Underwood PC, et al. The influence of body-mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol 2011;164:9951002.
  • 11
    Isobe T, Saitoh S, Takagi S et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 2005;153:9198.
  • 12
    Lu G, Chiem A, Anuurad E et al. Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. Transl Res 2007;149:317323.
  • 13
    Papadopoulos DP, Makris TK, Krespi PG et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich) 2005;7:729733.
  • 14
    Lely AT, Krikken JA, Bakker SJ et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab 2007;92:18211826.
  • 15
    Fargnoli JL, Fung TT, Olenczuk DM et al. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study. Am J Clin Nutr 2008;88:12131224.
  • 16
    Dutheil F, Lesourd B, Courteix D et al. Blood lipids and adipokines concentrations during a 6-month nutritional and physical activity intervention for metabolic syndrome treatment. Lipids Health Dis 2010;9:148.
  • 17
    Kawamoto R, Tabara Y, Kohara K et al. Alcohol drinking status is associated with serum high molecular weight adiponectin in community-dwelling Japanese men. J Atheroscler Thromb 2010;17:953962.
  • 18
    Rouen PA, Lukacs JL, Reame NE. Adipokine concentrations in nonobese women: a study of reproductive aging, body mass index, and menstrual cycle effects. Biol Res Nurs 2010;12:5461.
  • 19
    Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:10631069.
  • 20
    Ng K, Meyerhardt JA, Wu K et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26:29842991.
  • 21
    Tworoger SS, Gates MA, Gate MA et al. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 2009;69:18851891.
  • 22
    Tworoger SS, Eliassen AH, Kelesidis T et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007;92:15101516.
  • 23
    Lopez-Garcia E, Schulze MB, Fung TT et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004;80:10291035.
  • 24
    Arabi A, El-Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 2010;6:550561.
  • 25
    de Gonzalez Berrington A, Hartge P, Cerhan JR et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:22112219.
  • 26
    Zheng W, McLerran DF, Rolland B et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011;364:71929.
  • 27
    Ohashi K, Kihara S, Ouchi N et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006;47:11081116.
  • 28
    Kong J, Qiao G, Zhang Z, Liu SQ, Li YC. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney Int 2008;74:15771581.
  • 29
    Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003;88:327331.
  • 30
    Li YC, Kong J, Wei M et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229238.
  • 31
    Vaidya A, Forman JP, Williams JS. Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension. J Hum Hypertens 2010; e-pub ahead of print 2 December 2010.
  • 32
    Zhang Y, Kong J, Deb DK, Chang A, Li YC. Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol 2010;21:966973.
  • 33
    Vaidya A, Forman JP, Hopkins PN, Seely EW, Williams JS. 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst 2011; e-pub ahead of print 17 February 2011.
  • 34
    Yvan-Charvet L, Quignard-Boulangé A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 2011;79:162168.
  • 35
    Bader M. Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 2010;50:439465.
  • 36
    Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000;35:12701277.
  • 37
    Engeli S, Schling P, Gorzelniak K et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003;35:807825.
  • 38
    Kim S, Soltani-Bejnood M, Quignard-Boulange A et al. The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates Intrarenal Renin-Angiotensin System. J Biomed Biotechnol 2006;2006:27012.
  • 39
    Yasue S, Masuzaki H, Okada S et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens 2010;23:425431.